Metabolomics Profiling to Investigate the Pharmacologic Mechanisms of Berberine for the Treatment of High-Fat Diet-Induced Nonalcoholic Steatohepatitis
Table 1
Change in serum parameters of rats fed on a standard diet (NC), high-fat diet (M), or HFD with the berberine (Ber) treatment for eight weeks (, ).
Index
NC
M
Ber
ALT (U/L)
19.49 ± 4.68
40.67 ± 9.47**
20.92 ± 5.56##
AST (U/L)
199.88 ± 30.74
390.60 ± 59.13**
281.57 ± 70.86##
CHO (mmol/L)
1.68 ± 0.19
2.81 ± 0.79*
2.07 ± 0.22#
TG (mmol/L)
0.56 ± 0.04
1.65 ± 0.12*
0.65 ± 0.13##
LDL-C (mmol/L)
0.16 ± 0.02
0.81 ± 0.42*
0.54 ± 0.38
Glucose (mmol/L)
3.51 ± 0.67
4.74 ± 2.20*
3.24 ± 1.17#
Insulin (mIU/L)
16.67 ± 4.0
17.09 ± 2.40
15.77 ± 3.53
HOMA index
2.6 ± 0.68
3.6 ± 3.02*
2.3 ± 0.75#
Note: , compared with NC group; , compared with NC group; and , compared with M group.